Premium
Effects of A 1 ‐adenosine receptor antagonists on purinergic transmission in the guinea‐pig vas deferens in vitro
Author(s) -
Hardy Todd A,
Brock James A
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702514
Subject(s) - phentolamine , adenosine , vas deferens , endocrinology , medicine , adenosine receptor antagonist , purinergic receptor , adenosine receptor , chemistry , adenosine a1 receptor , neurotransmitter , yohimbine , biology , antagonist , receptor , agonist , stimulation
Intracellularly recorded excitatory junction potentials (e.j.ps) were used to study the effects of adenosine receptor antagonists on neurotransmitter release from postganglionic sympathetic nerve terminals in the guinea‐pig vas deferens in vitro . The A 1 adenosine receptor antagonists, 8‐phenyltheophylline (10 μ M ) and 8‐cyclopentyl‐1,3‐dipropylxanthine (0.1 μ M ), increased the amplitude of e.j.ps evoked during trains of 20 stimuli at 1 Hz in the presence, but not in the absence, of the α 2 ‐adrenoceptor antagonist, yohimbine (1 μ M ) or the non‐selective α‐adrenoceptor antagonist, phentolamine (1 μ M ). Adenosine (100 μ M ) reduced the amplitude of e.j.ps, both in the presence and in the absence of phentolamine (1 μ M ). This inhibitory effect of adenosine is most likely caused by a reduction in transmitter release as there was no detectable change in spontaneous e.j.p. amplitudes. In the presence of phentolamine, application of the adenosine uptake inhibitor, S‐(p‐nitrobenzyl)‐6‐thioinosine (0.1 μ M ), had no effect on e.j.p. amplitudes. The phosphodiesterase inhibitor, 3‐isobutyl‐1‐methylxanthine (100 μ M ), significantly increased the amplitudes of all e.j.ps evoked during trains of 20 stimuli at 1 Hz, both in the presence and in the absence of phentolamine (1 μ M ). These results suggest that endogenous adenosine modulates neurotransmitter release by an action at prejunctional A 1 adenosine receptors only when α 2 ‐adrenoceptors are blocked.British Journal of Pharmacology (1999) 126 , 1761–1768; doi: 10.1038/sj.bjp.0702514